It is clear that the current healthcare system in the US is a failure, and sadly, middle class families are usually those who are the hardest hit. We need to not only scrap Obamacare, but replace it with a sound alternative, such as the American Health Care Reform Act of 2015. This new healthcare system should foster a more competitive insurance market by allowing individuals and companies to purchase plans across state lines, thereby driving the cost down for consumers. We also need to be doing all we can to support and enable innovation in healthcare—such as health apps, telehealth, and new devices. These technologies would increase access to healthcare services, and would increase quality by providing physicians and patients with more information to make better decisions.
More on Healthcare
Washington, D.C. - Today, Congressman Tom Marino (PA-10) and Congresswoman Karen Bass (CA-37) introduced H.R.4769, the Helping Americans Seek Treatment Act of 2018.
Washington, D.C.—Today, the United States Senate Committee on the Judiciary held a hearing titled “Oversight of the Ensuring Patient Access and Effective Drug Enforcement Act.”
Congressman Tom Marino (PA-10) submitted the following statement for the record:
Washington D.C. - Congressman Tom Marino (PA-10) issued the following statement after President Donald Trump announced the opioid crisis is a national public health emergency:
ICYMI: Rep. Marino Op-Ed: Truth is the Key to Solving the Opioid Crisis
October 25, 2017
““What is truth?” was Pontius Pilate’s famous question to Jesus. In our nation’s capital and the media, the answer seems to be “whatever the Washington Post says it is.”
ICYMI: Implausible Rep. Tom Marino led a Bipartisan Conspiracy to Worsen Drug Addiction Crisis
Bipartisan Drug Cartel?
The Wall Street Journal
The Editorial Board
October 24, 2017
Washington, D.C.— Congressman Tom Marino (R-PA-10) issued the following statement after requesting that President Donald Trump withdraw his name from consideration to lead the Office of National Drug Control Policy (ONDCP):
“Today I informed President Donald Trump of my intent to withdraw my name from any further consideration to lead ONDCP.
Washington, D.C.—Tomorrow at 1:00 p.m. Congressman Tom Marino (PA-10) will hold a hearing on anticompetitive behavior and the health care marketplace.
Washington, D.C.--Today, the U.S. Food and Drug Administration (FDA) held a public meeting to solicit input in areas where the FDA’s rules are being used in ways that create obstacles and delays. FDA Commissioner Scott Gottlieb, M.D., has shown a commitment to ensuring that generic manufacturers have access to promote competition.
Washington, D.C. -- Congressman Tom Marino (PA-10) and Congressman John Lewis (GA-05) reintroduced H.R. 2644, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. This bill is aimed at improving the lives of those suffering with kidney disease by identifying barriers for transplantation and improving donation rates.
Washington D.C. – Today, Congressman Tom Marino (PA-10) and Congressman James P. McGovern (MA-02), co-chairs of the Congressional Cystic Fibrosis Caucus, introduced H.Con.Res. 58, a bipartisan resolution to recognize May as Cystic Fibrosis Awareness Month. This resolution recognizes the Cystic Fibrosis community for their dedication to their patients, acknowledges the investments and scientific achievements that have improved patients’ lives, and urges researchers, developers, patients, and providers to do everything possible to find a cure for this deadly disease.